Tariffs Threaten Healthcare: Act Now!
Monday, May 19, 2025 11:40 am ET
5min read HOSPITALS AND HEALTH SYSTEMS UNDER SIEGE!
Most hospitals and health systems are the largest organizations in our communities, providing critical services needed by every one of our neighbors. We take care of our communities as best as possible — which means advocating for the support and resources we need.
TARIFFS ARE COMING FOR YOUR MEDICAL SUPPLIES!
A series of tariffs recently implemented could have significant implications for healthcare. A large proportion of medical goods currently comes from international sources, including pharmaceuticals, medical devices, and personal protective equipment, as well as other low-margin, high-use essentials like syringes, needles, and blood pressure cuffs.
GET READY FOR THE FALLOUT!
Tariffs on these items could impact patient care by jeopardizing the availability of vital medications and essential healthcare devices. They also could raise costs for hospitals and heighten shortages and supply chain disruptions.
WE’VE SEEN THIS BEFORE!
We’ve already seen the impact of supply chain disruptions in the aftermath of Hurricane Helene. To continue providing the care our communities rely on, hospitals and health systems need exemptions to ensure access to essential imports.
AHA TO THE RESCUE!
AHA President and CEO Rick Pollack has urged the administration to provide tariff exemptions for medications and medical supplies. The AHA also recently responded to a request for public comment on the Department of Commerce’s Section 232 national security investigation on pharmaceutical and pharmaceutical ingredient imports, urging the administration to maintain tariff exemptions to minimize inadvertent disruptions to patient care.
YOU NEED TO ACT NOW!
There also is an important opportunity to make the supply chain more resilient. AHA has been working with Congress to urge consideration of legislation that would support efforts to proactively map and assess the pharmaceutical, medical device, and equipment supply chains.
DON’T MISS OUT ON THIS CRITICAL INFORMATION!
I will be talking with Brian Pomper, partner with Akin Gump Strauss Hauer & Feld, and Akin Demehin, AHA’s vice president of quality and patient safety policy, for an upcoming Leadership Dialogue on tariffs. Join us to learn about the potential impact on healthcare and how leaders can prepare.
HELPING YOU HELP COMMUNITIES: KEY AHA RESOURCES
Most hospitals and health systems are the largest organizations in our communities, providing critical services needed by every one of our neighbors. We take care of our communities as best as possible — which means advocating for the support and resources we need.
TARIFFS ARE COMING FOR YOUR MEDICAL SUPPLIES!
A series of tariffs recently implemented could have significant implications for healthcare. A large proportion of medical goods currently comes from international sources, including pharmaceuticals, medical devices, and personal protective equipment, as well as other low-margin, high-use essentials like syringes, needles, and blood pressure cuffs.
GET READY FOR THE FALLOUT!
Tariffs on these items could impact patient care by jeopardizing the availability of vital medications and essential healthcare devices. They also could raise costs for hospitals and heighten shortages and supply chain disruptions.
WE’VE SEEN THIS BEFORE!
We’ve already seen the impact of supply chain disruptions in the aftermath of Hurricane Helene. To continue providing the care our communities rely on, hospitals and health systems need exemptions to ensure access to essential imports.
AHA TO THE RESCUE!
AHA President and CEO Rick Pollack has urged the administration to provide tariff exemptions for medications and medical supplies. The AHA also recently responded to a request for public comment on the Department of Commerce’s Section 232 national security investigation on pharmaceutical and pharmaceutical ingredient imports, urging the administration to maintain tariff exemptions to minimize inadvertent disruptions to patient care.
YOU NEED TO ACT NOW!
There also is an important opportunity to make the supply chain more resilient. AHA has been working with Congress to urge consideration of legislation that would support efforts to proactively map and assess the pharmaceutical, medical device, and equipment supply chains.
DON’T MISS OUT ON THIS CRITICAL INFORMATION!
I will be talking with Brian Pomper, partner with Akin Gump Strauss Hauer & Feld, and Akin Demehin, AHA’s vice president of quality and patient safety policy, for an upcoming Leadership Dialogue on tariffs. Join us to learn about the potential impact on healthcare and how leaders can prepare.
HELPING YOU HELP COMMUNITIES: KEY AHA RESOURCES
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
_442a2dcc1749832873286.jpeg)
_e68fac6d1749831664430.jpeg)
